Azapirones for generalized anxiety disorder
Cheryl A. Chessick(University of Colorado Health), Juliano JSS dos Santos Souza(Universidade Federal de Santa Maria), Flávio Kapczinski(Universidade Federal do Rio Grande do Sul), Michael E. Thase(Veterans Health Administration), Michael H. Allen(East Tennessee State University), Angelo ABC Batista Miralha da Cunha(Universidade Federal de Santa Maria), Maurício Silva de Lima(Universidade Federal de Alagoas)
Cited by 141
Related Papers
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
|American Journal of Psychiatry|2007|5.3k
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k